GUFICBIO — Gufic Biosciences Balance Sheet
0.000.00%
- IN₹38.26bn
- IN₹41.02bn
- IN₹8.07bn
Annual balance sheet for Gufic Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 163 | 131 | 265 | 467 | 135 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,337 | 1,523 | 1,778 | 2,322 | 3,828 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,733 | 2,606 | 3,208 | 4,641 | 6,005 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,126 | 1,129 | 1,554 | 3,285 | 4,603 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 4,075 | 3,921 | 5,214 | 8,612 | 10,925 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,398 | 1,637 | 1,864 | 2,882 | 3,720 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,782 | 2,186 | 2,523 | 5,134 | 5,600 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,293 | 1,734 | 2,691 | 3,478 | 5,326 |
Total Liabilities & Shareholders' Equity | 4,075 | 3,921 | 5,214 | 8,612 | 10,925 |
Total Common Shares Outstanding |